Life Science Tools and Reagents: Global Markets

Report Highlights

The global market for life sciences tools and reagents reached $45.9 billion in 2014 and $48.2 billion in 2015. The market should reach $58.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 3.8% from 2015 to 2020.

Report Includes

• An overview of the global market for life science tools and reagents.
• Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
• Identification of existing products as well as new potential markets for novel products and assay development.
• Discussion of how scientific trends, government policies, and the economy in general affect this industrial market as compared to pharmaceutical and drug discovery ventures; for example, the launches of new reagents or products is not affected by strict FDA guidelines.
• Examination of drivers and challenges in each segment of the industry.
• Relevant patent analysis.
• Comprehensive company profiles of major players in the market.

Report Scope

The scope of this study involves the tools and reagents employed in the life sciences markets. The life sciences markets include the life science elements contributing to pharmaceutical discovery, but excluding drug discovery and development (such as clinical trials etc) per se. The tools and reagents covered in this report are used to conduct research in the domains of genomics (DNA and RNA research), proteomics, cell biology research, epigenetics, metabolomics, bioinformatics, imaging and microscopy and stem cell research. Also included are the markets of recombinant proteins, antibodies and animal models.

Excluded from this report are immunoassays employed in life science research. Immunoassays include enzyme immunoassays, fluorescent immunoassays, chemiluminescence immunoassays, radioimmunoassays and others. They have applications in diagnostics, neonatal screening, protein detection, etc. In addition, filtration devices (cross-flow filtration, membrane filters, micron filters, etc.), blotting membranes and bioreactors used for the production of recombinant proteins and enzymes in bacterial and mammalian cell cultures will not be considered in this report.

This study surveys each market in all the geographic regions including North America, Europe and Emerging countries. The Emerging market covers the countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.

BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The latest developments including new products, mergers and acquisitions in each market are also dealt with in detail. Also included in the report are relevant patent analysis and comprehensive profiles of companies that are dominant in the life science tools and reagents industry. The key market players are Thermo Fisher Scientific Inc., Merck KGaA (includes EMD Millipore and Sigma-Aldrich), Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Danaher Corp., Bio-Techne Corp., Waters Corp., Bruker Corp., Perkin Elmer Inc., Qiagen N.V., Becton, Dickinson and Company (includes BD Life Sciences), Illumina Inc., Roche, Promega Corp. and many others.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.